Published in Surg Today on April 30, 2009
Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass. Exp Clin Cardiol (2012) 0.96
Intra-aortic balloon pump for hemodynamic support in hepatobiliary surgery: report of a case. Surg Today (2012) 0.75
Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet (2002) 3.18
Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA (2007) 2.90
Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J (2002) 1.83
Preconditioning effects of levosimendan in coronary artery bypass grafting--a pilot study. Br J Anaesth (2006) 1.64
Effect of levosimendan on ventriculo-arterial coupling in patients with ischemic cardiomyopathy. Acta Anaesthesiol Scand (2007) 1.42
Inoprotection: the perioperative role of levosimendan. Anaesth Intensive Care (2007) 1.40
Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake. Circulation (2003) 1.19
Effects of intravenous levosimendan on human coronary vasomotor regulation, left ventricular wall stress, and myocardial oxygen uptake. Circulation (2005) 1.15
Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J (1998) 1.07
Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use. Eur J Cardiothorac Surg (2007) 1.01
The cardioprotective effects of levosimendan: preclinical and clinical evidence. J Cardiovasc Pharmacol (2007) 0.97
Preconditioning effects of levosimendan in a rabbit cardiac ischemia-reperfusion model. J Cardiovasc Pharmacol (2006) 0.95
The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia. J Am Coll Cardiol (2004) 0.93
Levosimendan in off-pump coronary artery bypass: a four-times masked controlled study. J Cardiovasc Pharmacol (2004) 0.90
Preconditioning with levosimendan prevents contractile dysfunction due to H2O2-induced oxidative stress in human myocardium. J Cardiovasc Pharmacol (2007) 0.88
Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure. J Am Coll Cardiol (1986) 0.87
Levosimendan enhances cardiac performance after cardiopulmonary bypass: a prospective, randomized placebo-controlled trial. J Cardiovasc Pharmacol (1999) 0.86
Effects of levosimendan on myocardial ischaemia-reperfusion injury. Eur J Anaesthesiol (2007) 0.85
Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines. Acta Anaesthesiol Scand (2003) 0.84
Levosimendan in patients with cardiogenic shock undergoing surgical revascularization: a case series. Med Sci Monit (2004) 0.84
Effects of levosimendan versus dobutamine on long-term survival of patients with cardiogenic shock after primary coronary angioplasty. Int J Cardiol (2007) 0.82
Effects of levosimendan on coronary artery flow and cardiac performance in patients with advanced heart failure. Eur J Heart Fail (2007) 0.81
Effects of levosimendan on myocardial infarct size and hemodynamics in a closed-chest porcine ischemia-reperfusion model. Cardiovasc Drugs Ther (2006) 0.81
Levosimendan in patients with acute myocardial ischaemia undergoing emergency surgical revascularization. Eur J Anaesthesiol (2007) 0.80
Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock. Crit Care Med (2007) 0.80
Levosimendan in cardiac surgery. J Cardiothorac Vasc Anesth (2005) 0.79
Levosimendan cardioprotection reduces the metabolic response during temporary regional coronary occlusion in an open chest pig model. Acta Anaesthesiol Scand (2006) 0.79
Early and sustained haemodynamic improvement with levosimendan compared to intraaortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction. Acute Card Care (2008) 0.78
Levosimendan improves hemodynamics and coronary flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction and left ventricular dysfunction. Am Heart J (2005) 0.78
Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics. Eur J Heart Fail (2006) 0.77
Effects of levosimendan versus dobutamine on left ventricular diastolic function in patients with cardiogenic shock after primary angioplasty. Int J Cardiol (2007) 0.77
Intravenous enoximone or dobutamine for severe heart failure after acute myocardial infarction: a randomized double-blind trial. Eur Heart J (1993) 0.77
Levosimendan for weaning from cardiopulmonary bypass after coronary artery bypass grafting. Heart Lung Circ (2006) 0.76
Hemodynamic and humoral effects of atrial natriuretic peptide on pulmonary circulation after cardiac surgery. Surg Today (2008) 0.76
Effects of levosimendan on left ventricular diastolic function after primary angioplasty for acute anterior myocardial infarction: a Doppler echocardiographic study. J Am Soc Echocardiogr (2006) 0.76
Levosimendan allows detection of contractile reserve in patients with chronic ischaemic left ventricular dysfunction and non-diagnostic dobutamine echocardiography. Eur J Heart Fail (2007) 0.75
Considerations on the efficacy and safety of levosimendan in ischemic heart failure. Ital Heart J (2003) 0.75
The use of the novel calcium sensitizer levosimendan in critically ill patients. Anaesth Intensive Care (2004) 0.75
Successful use of levosimendan in a patient during cardiopulmonary bypass. J Card Surg (2007) 0.75
Pharmacologic treatment of heart failure due to ventricular dysfunction by myocardial stunning: potential role of levosimendan. Am J Cardiovasc Drugs (2006) 0.75